Medicure Inc

NGQ1

Company Profile

  • Business description

    Medicure Inc is a biopharmaceutical company. It is involved in the research, clinical development, and commercialization of human therapeutics for the United States hospital market. Further, it also operates a specialty pharmacy in the United States of America. The company's present focus is the sale and marketing of its cardiovascular products, AGGRASTAT, ZYPITAMAG, and developing its e-commerce and mail order pharmaceutical business. The company operates in two segments namely, Marketing and distribution of commercial products and, Retail and mail order pharmacy. The majority of the company's revenue is generated from the marketing and distribution of the commercial products segment.

  • Contact

    2 - 1250 Waverley Street
    WinnipegMBR3T 6C6
    CAN

    T: +1 204 487-7412

    E: [email protected]

    https://www.medicure.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    25

Stocks News & Analysis

stocks

Are investors missing the boat on this future ASX leader?

The market is underestimating the clear path to profitability.
stocks

ASX shares plunge but remain undervalued

Shares drop 17% after guidance is revised but we still see value.
stocks

Ask the analyst: Why have markets shunned APA Group?

Australia's premier gas infrastructure firm used to be a market darling, but its shares have taken a severe de-rating in recent years.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,494.3022.500.27%
CAC 407,423.6715.030.20%
DAX 4020,271.33138.480.69%
Dow JONES (US)42,518.28221.160.52%
FTSE 1008,201.5422.65-0.28%
HKSE19,219.78345.641.83%
NASDAQ19,044.3943.71-0.23%
Nikkei 22538,474.30716.10-1.83%
NZX 50 Index12,902.6918.310.14%
S&P 5005,842.916.690.11%
S&P/ASX 2008,251.8020.800.25%
SSE Composite Index3,240.9480.192.54%

Market Movers